Blockchain Registration Transaction Record

InMed Pharmaceuticals (NASDAQ: INM) Receives Three U.S. Patents Strengthening Its Patent Portfolio

InMed Pharmaceuticals (NASDAQ: INM) has received three U.S. patents, further strengthening its patent portfolio. This news showcases the company's commitment to developing new drug treatments and protecting their innovations.

InMed Pharmaceuticals (NASDAQ: INM) Receives Three U.S. Patents Strengthening Its Patent Portfolio

This news highlights InMed Pharmaceuticals' commitment to developing new drug treatments and protecting their innovations, impacting the pharmaceutical industry and potential future medical breakthroughs.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xe10f1d6dc6eeaaa7d93292861193d65f3a34caa3c825c80b42302ad843c3f596
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintwarprsRJ-032f175ab745ce205a5bd3becc348fdb